A pair of Israeli citizens accused by regulators last year of making millions of dollars through a global insider trading ring have been criminally charged in New York federal court, according to an indictment unsealed Thursday.
A New Jersey federal judge took the unusual step of reversing an order telling the U.S. Patent and Trademark Office to add two inventors to a Janssen Pharmaceuticals Inc. patent after its rival Teva informed the court that it had never consented to the inventors' addition.
United Therapeutics Corp. will have to turn over its chief financial officer's text messages for rival drugmaker Sandoz Inc.'s antitrust suit, although Sandoz must also relinquish evidence related to getting government approval of its competing product, a New Jersey federal judge ruled Thursday.
A former Centers for Medicare & Medicaid Services worker and two former hedge fund analysts on Wednesday urged the Second Circuit to reverse all of their insider trading convictions following the U.S. Supreme Court's remand in light of its Bridgegate decision, saying the government can't salvage two counts of conviction out of many it now agrees should be set aside.
Three teachers went to trial against Monsanto on Wednesday over neurological damage allegedly caused by the company's PCBs lingering in a school building decades after regulators clamped down on the highly toxic thermal insulation fluids.
After its original decision was sent back down from the Seventh Circuit, an Illinois federal court has made an about-face, declaring that a home health care company did break federal kickback laws.
Lexicon Pharmaceuticals investors urged a Fifth Circuit panel Wednesday to revive their lawsuit claiming the company overpromised on its ability to bring its prospective diabetes drug Zynquista to market, saying the district judge mislabeled investors' allegations as "fraud by hindsight."
Ex-Theranos CEO Elizabeth Holmes' recent attorney-client privilege loss in a pretrial dispute over her communications with Boies Schiller Flexner LLP serves as "a cautionary tale" to corporate attorneys that the predominant legal standard disfavors executives and that it's incumbent on lawyers to make clear who their clients are, according to legal experts.
World Trade Organization members agreed Wednesday to speed up talks over competing proposals to boost global COVID-19 vaccine access, including a hotly contested temporary waiver of intellectual property protections for vaccines.
Boston-based drug discovery startup Valo Health LLC said Wednesday that it plans to go public at a valuation of about $2.8 billion through a merger with a blank check company, in a deal led by Goodwin Procter LLP and Latham & Watkins LLP.
ChemoCentryx Inc. has been hit with a proposed investor class action in California federal court accusing the biopharmaceutical company of overstating the efficacy of its newly developed treatment for an autoimmune disease called ANCA vasculitis.
Boston Scientific said Tuesday it has named one of its longtime in-house attorneys who most recently was vice president and chief corporate counsel as its next top lawyer.
The Judicial Panel on Multidistrict Litigation said Monday that MSP Recovery's opioid suit against CVS belongs in Ohio federal court as part of multidistrict litigation there, declining to vacate an order conditionally transferring the action.
A Delaware federal judge's invalidation of a patent covering UCB Inc.'s Parkinson's disease treatment Neupro was invoked Tuesday in Vermont federal court to help Mylan beat patent litigation over its generic version of the drug.
The Judicial Panel on Multidistrict Litigation picked Bayer CropScience's home territory in the Eastern District of Missouri on Tuesday to host the two dozen consolidated cases accusing Bayer and other agricultural suppliers of fixing prices on crop inputs such as seeds and insecticides.
Glenmark filed an unusual supplement Monday to a hearing over the U.S. Department of Justice's bid to disqualify Morgan Lewis & Bockius LLP from representing the drugmaker in a price-fixing case, saying a technical glitch prevented a recording of Glenmark's waiver of any conflict of interest.
Teva Pharmaceuticals lodged a new infringement suit against rival Eli Lilly in Massachusetts federal court Tuesday mere hours after the U.S. Patent and Trademark Office issued the company two new patents covering the Israeli drugmaker's blockbuster migraine drug Ajovy.
Washington state's cannabis regulator has announced that it will let licensed marijuana sellers hand out pre-rolled joints to adults who receive COVID-19 vaccinations, but an industry group for pot retailers said the state's rules may be too restrictive to make the plan workable.
The Aleutian Pribilof Islands Association Inc. lodged anti-racketeering claims against Juul Labs in a California federal court for knowingly targeting American Indian and Alaska Native youth in its advertisements within the Aleutian Pribilof Islands.
The Third Circuit revived a pharmaceutical laboratory's trade secrets lawsuit against a former executive and Aurobindo Pharma units on Tuesday, ruling that a district court applied an improperly heavy burden on the lab to establish the proprietary information at issue and show how it was misused.
Pointing to uncertainty around Mallinckrodt ARD LLC's pending bankruptcy proceedings in Delaware, the U.S. Judicial Panel on Multidistrict Litigation deemed it "premature" on Monday to centralize a string of antitrust cases over the company's sales of the anti-seizure drug Acthar.
A Pennsylvania appeals court ruled in a published decision on Tuesday that a warehouse worker who was fired from his job after failing a drug test could still receive unemployment benefits, based on testimony that he told his employer about his medical marijuana prescription.
Canadian cannabis giant Tilray has reached a settlement with a Florida grower in a dispute arising from a 2015 agreement to apply for medical cannabis licenses, according to a notice filed with a Washington state court Tuesday.
The FTC declared its enduring power to seek permanent injunctive relief through the courts in its suit against a multilevel marketing company, shooting down the accused scammer's use of the U.S. Supreme Court ruling in AMG Capital to bid for an early win.
A Delaware bankruptcy judge took counsel for an Illinois city to task for what he said were frivolous filings in the city's fight with drugmaker Mallinckrodt for allegedly inflating the price of its anti-seizure drug Acthar.
The U.S. Supreme Court should hear Janssen Pharmaceuticals v. AY, and rule that drugmakers are not required to include off-label warnings, in order to protect companies from being held liable for failing to do what federal law prohibits, say Sheldon Bradshaw and Lisa Dwyer at King & Spalding.
As the legal industry continues to change in the post-pandemic world, law firms should adapt to client demands by constantly measuring and managing the profitability of their services, says Joseph Altonji at LawVision.
The Federal Circuit recently employed a flexible standard for constructing Olaplex's hair care patent claims in a case against L'Oreal, but more precise claim drafting could have avoided altogether a problem with claims for component amounts in product formulations, says Philip Hamzik at Wolf Greenfield.
Recent rulings shed light on how courts and international arbitration tribunals decide if litigation funding materials are discoverable and reaffirm best practices that attorneys should follow when communicating with funders, say Justin Maleson at Longford Capital and Michele Slachetka and Christian Plummer at Jenner & Block.
The U.S. Supreme Court's decision in AMG Capital v. Federal Trade Commission, limiting the agency's ability to seek equitable monetary relief under the FTC Act, will likely also restrain the U.S. Food and Drug Administration's authority under the Federal Food, Drug, and Cosmetic Act, due to similarities between the laws, say Joshua Oyster and Jenna McCarthy at Ropes & Gray.
Employers can expect more actions against wage-fixing or no-poach agreements as the U.S. Department of Justice's Antitrust Division cracks down on labor market collusion, so companies should consider tailoring these agreements on their scope, duration and definition of nonsolicitation, say attorneys at Duane Morris.
New amendments to the West Virginia Consumer Credit and Protection Act will help businesses in the state, particularly in the financial services industry, by better defining the process for presuit notice and opportunity to cure, and by making it easier to recover attorney fees, say Andrew Narod and Jared Searls at Bradley Arant.
Well-grounded scientific testimony in judicial proceedings has become more essential than ever, especially with large verdicts at stake in cases concerning hot-button issues like talc and climate change, so judges must act as gatekeepers to exclude unsound science from jury trials, says Lawrence Ebner at the Atlantic Legal Foundation.
The Federal Circuit's recent holding in Bio-Rad v. International Trade Commission, that an assignment clause wasn’t enough to claim patent ownership where the conception date followed former inventors’ employment, shows companies and workers the importance of specificity in drafting contractual limitations, say Bryan Vogel and Derrick Carman at Robins Kaplan.
Resolution of the legal uncertainty presented by the dueling federal and state approaches to cannabis will pave the way for legal cannabis businesses to access the insurance protections the industry needs for everything from workers' compensation to auto insurance to general liability, says Christy Thiems at the American Property Casualty Insurance Association.
This year's law graduates and other young attorneys must recognize that the practice of law tests and rewards different skills and characteristics than law school, and that what makes a lawyer valuable changes over time, says Vernon Winters, retired partner at Sidley.
For pharmaceutical company mergers and acquisitions, increased antitrust scrutiny under the Biden administration, combined with international coordination of review and enforcement, will likely translate into longer, more in-depth and more expensive merger reviews, say attorneys at Faegre Drinker.
The COVID-19 crisis has allowed lawyers to hone remote advocacy strategies and effectively represent clients with minimal travel — abilities that have benefited working parents and should be utilized long after the pandemic is over, says Chelsea Loughran at Wolf Greenfield.
As the cannabis M&A market heats up, one way cannabis operators can improve merger or acquisition potential is to have a risk-based compliance program that aligns regulator and operator interests, say Katrina Skinner at Burns & Levinson and Brion Nazzaro at the Association of Certified Commercial Cannabis Experts.
Employment discrimination class actions that rely on statistical representations could look different following the recent Olean v. Bumble Bee antitrust ruling, due to the Ninth Circuit's scrutiny of models that obscure the extent of uninjured plaintiff membership, say attorneys at Orrick.